Top 10 Mid Cap Companies To Watch For 2015

Top 10 Mid Cap Companies To Watch For 2015: Ironwood Pharmaceuticals Inc.(IRWD)

Ironwood Pharmaceuticals, Inc. discovers, develops, and commercializes medicines targeting therapeutic needs. The company is developing Linaclotide, a first-in-class compound that is in Phase III clinical trials for the treatment of irritable bowel syndrome with constipation, chronic constipation, and other lower gastrointestinal conditions. It also focuses on the research and development of early stage product candidates and preclinical research in various therapeutic areas, including gastrointestinal disease, pain and inflammation, respiratory disease, and cardiovascular disease. The company has a collaboration agreement with Forest Laboratories, Inc. to jointly develop and commercialize linaclotide in North America; a license agreement with Almirall, S.A. to develop and commercialize linaclotide in Europe; and a license agreement with Astellas Pharma Inc. that provides Astellas Pharma with the right to develop and commercialize linaclotide in Japan, South Korea, Taiwan, Thailand, the Philippines, and Indonesia. It serves patients, payors, and healthcare providers. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was founded in 1998 and is headquartered in Cambridge, Massachusetts.

Advisors' Opinion:

• [By Lee Jackson]

  While very upbeat on the sector as a whole, UBS was very cautious on sell-rated Ironwood Pharmaceuticals, Inc (NASDAQ: IRWD) and ImmunoGen Inc. (NASDAQ: IMGN). Neutral-rated Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and Seattle Genetics Inc. (NASDAQ: SGEN) were also viewed with a skeptical eye.

• [By Keith Speights]

  Flood of expenses
  Ironwood Pharmaceuticals (NASDAQ: IRWD  ) shares fell 12% this week, after the company reported first-quarter results. A big part of the drugmaker's problems stemmed from soaring sales and admin! istrative costs.

• [By gurujx]

  Ironwood Pharmaceuticals, Inc. (IRWD) Reached the 3-year Low of $10.02

  The prices of Ironwood Pharmaceuticals, Inc. (IRWD) shares have declined to close to the 3-year low of $10.02, which is 51.0% off the 3-year high of $19.67.

• [By Sean Williams]

  What: Shares of Ironwood Pharmaceuticals (NASDAQ: IRWD  ) , a specialty biopharmaceutical company, gained as much as 11% after the company reported better-than-expected second-quarter earnings results.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-10-mid-cap-companies-to-watch-for-2015-2.html